Skip to content
Biodatica
Start free

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Zhengzhou, Henan

OncologyPhase IIListed · 688266.SH

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase II trial registered: Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer

2mo agoTrial registeredApr 30, 2026Source filing (opens the source filing in a new tab)

Momentum

83no change

Momentum 83 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Feb 1, 2026

    NSCLC (Advanced Non-small Cell Lung Cancer), SCLC, Extensive Stage · NOT_YET_RECRUITING · sponsor: Henan Cancer Hospital · Anlotinib in Cross-line Treatment of NSCLC and SCLC

    ClinicalTrials.gov · NCT07400575 (opens the source filing in a new tab)

  2. Trial

    PHASE1/PHASE2 registered

    Sep 8, 2025

    Leptomeningeal Metastasis From Lung Cancer · RECRUITING · sponsor: Henan Cancer Hospital · Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer

    ClinicalTrials.gov · NCT07559097 (opens the source filing in a new tab)

  3. Trial

    PHASE1/PHASE2 registered

    May 1, 2025

    Solid Tumors · NOT_YET_RECRUITING · sponsor: Henan Cancer Hospital · Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors

    ClinicalTrials.gov · NCT06955390 (opens the source filing in a new tab)

  4. Trial

    PHASE2 registered

    Jan 15, 2025

    SCLC, Extensive Stage · NOT_YET_RECRUITING · sponsor: Henan Cancer Hospital · Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

    ClinicalTrials.gov · NCT06793228 (opens the source filing in a new tab)

  5. Trial

    PHASE1/PHASE2 registered

    Oct 27, 2023

    Small Cell Lung Cancer, Neuroendocrine Carcinoma · RECRUITING · sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

    ClinicalTrials.gov · NCT05978284 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources